Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-11

Clinical Trial Update: Mirabegron Combined With Behavioral Intervention for Overactive Bladder:a Prospective Multicenter Randomized Controlled Clinical Study [Phase 4]

View source ↗

Summary

Prospective multicenter randomized controlled Phase 4 trial evaluating mirabegron combined with behavioral intervention for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Overactive Bladder | Phase 4 | Status: UNKNOWN